Ludwig Hantson insider trades

Open-market stock purchases and sales by Ludwig Hantson, Director at Ionis Pharmaceuticals Inc, from SEC Form 4 filings since May 7, 2010.

Recent trades

DateStockTradeValue
Jul 15, 2026IONS Ionis Pharmaceuticals IncBought (not open market)—
Jun 4, 2026IONS Ionis Pharmaceuticals IncBought (not open market)—
Apr 7, 2026HOLX Hologic IncSold (not open market)—
Apr 7, 2026HOLX Hologic IncSold (not open market)$83.6K
Apr 7, 2026HOLX Hologic IncSold (not open market)$305K
Apr 7, 2026HOLX Hologic IncSold (not open market)$347K
Apr 7, 2026HOLX Hologic IncSold (not open market)$359K
Apr 7, 2026HOLX Hologic IncSold (not open market)$372K
Apr 7, 2026HOLX Hologic IncSold (not open market)$330K
Apr 7, 2026HOLX Hologic IncSold (not open market)$346K
Apr 7, 2026HOLX Hologic IncSold (not open market)$356K
Feb 26, 2026HOLX Hologic IncBought (not open market)—

Companies traded

  • IONS Ionis Pharmaceuticals Inc: other filings, last Jul 15, 2026
  • HOLX Hologic Inc: other filings, last Apr 7, 2026
  • ALXN Alexion Pharmaceuticals, Inc: 1 buy, 3 sales, last Jul 21, 2021
  • BXLT Baxalta Inc: other filings, last Jun 3, 2016
  • BAX Baxter International Inc: 4 sales, last Jun 1, 2015

Get free alerts when Ludwig Hantson files a new trade →